Anavex Life Sciences Corp (AVXL)

[nidan7500]

NWDR...EXCELLENT, informative, rational post. I agree w/everything except for one thing. I believe the dynamics of the communications systems today and the scope(s) of A2-73 treatments along with changes in FDA (and other) regulatory bodies will serve to accelerate change in patient care. We may see concurrent/simultaneous treatment breakouts WW. If A2-73 is an effective treatment people WW will respond quickly on behalf of their patient/family member/other. No need for serial trials, IMO.

I believe the FDA's new mode (RWE) reasoning and the fact that A2-73 has no AE that we are aware of will quickly (read spontaneously) drive a demand process. And, speaking of positive, how about sharing such treatment knowledge WW? All CNS patients WW, regardless of country/politics get an opportunity for treatment are candidates. Yes, a bit of fantasy but not out of the question.

I am hopeful that Dr. M.'s thesis on restored CNS homeostasis restorative/regenerative capability is proven true and that will reduce clinical failure rates from those we have seen till now.

Bottom line, the whole time line for climbing out of the treatment hole we are in will be greatly accelerated.